{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:26:37Z","timestamp":1769124397551,"version":"3.49.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010232","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000}}],"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chagas disease (CD) has become an emerging global health problem in association with the immigration of individuals from endemic areas (in LatinAmerica) to other countries.Spain is the country in Europe with the highest number of CD cases. Concerning pediatric CD, treatment is not only better tolerated by younger children but also has greater cure possibilities. The aim of this study was to describe clinical and epidemiological aspects of CD in a pediatric population diagnosed of 10 hospitals in the Community of Madrid during the 2004\u20132018 period, as well as the safety and efficacy of CD treatment on this population.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/Principal findings<\/jats:title>\n<jats:p>A multicenter, retrospective, descriptive study was conducted. The studied population included all identified children under the age of 18 with a diagnosis of CD. Diagnosis was performed with a positive parasitological test (with subsequent confirmation) or confirmed persistence of positive serology beyond 9 months, for children younger than one year-old, and with two different positive serological tests, for children older than one.<\/jats:p>\n<jats:p>Fifty-one children were included (59% male; 50.9% born in Spain). All mothers were from Latin America. The median age at diagnosis was 0.7 months for those under one year of age, and 11.08 years for those older than one year-old. Only one case presented a symptomatic course (hydrops faetalis, haemodynamic instability at birth, ascites, anaemia). For 94% treatment was completed. Considering patients who received benznidazole (47), AE were recorded in 48,9%. Among the 32 patients older than one year-old treated with benznidazole, 18 (56.25%) had adverse events whereas in the 15 under one year, 5(33,3%) did. Eigtheen (78.2%) of the patients with benznidazole AE were older than one year-old(median age 11.4 years). Of the patients treated with nifurtimox (9), AE were reported in 3 cases (33,3%).<\/jats:p>\n<jats:p>Cure was confirmed in 80% of the children under one year-old vs 4.3% in those older (p&lt;0.001). Loss to follow- up occurred in 35.3% of patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions\/Significances<\/jats:title>\n<jats:p>Screening programs of CD since birth allow early diagnosis and treatment, with a significantly higher cure rate in children treated before one year of age, with lower incidence of adverse events. The high proportion of patients lost to follow-up in this vulnerable population is of concern.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0010232","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T18:48:34Z","timestamp":1645728514000},"page":"e0010232","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pediatric Chagas disease in the non-endemic area of Madrid: A fifteen-year review (2004\u20132018)"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-5166","authenticated-orcid":true,"given":"Luz Yadira","family":"Bravo-Gallego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-0423","authenticated-orcid":true,"given":"Laura","family":"Francisco-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0250-888X","authenticated-orcid":true,"given":"\u00c1lvaro","family":"V\u00e1zquez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagros","family":"Garc\u00eda-L\u00f3pez Hortelano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"L\u00f3pez V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6917-8980","authenticated-orcid":true,"given":"Luis Ignacio","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Epalza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Bel\u00e9n","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Cilleruelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-5184","authenticated-orcid":true,"given":"Tania","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iciar","family":"Olabarrieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-3100","authenticated-orcid":true,"given":"Mar\u00eda","family":"Flores-Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Tom\u00e1s","family":"Ramos Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Gonz\u00e1lez-Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"pntd.0010232.ref001","unstructured":"World Health Organization (WHO). Working to overcome the global impact of neglected tropical disease. First WHO report on neglected tropical diseases. 2010. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/44440"},{"key":"pntd.0010232.ref002","unstructured":"World Health Organization (WHO). Chagas disease (American trypanosomiasis).2021. [consulted January 2022] Available from: https:\/\/www.who.int\/health-topics\/chagas-disease#tab=tab_1"},{"key":"pntd.0010232.ref003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1471-0528.12396","article-title":"Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta analysis.","volume":"21","author":"EJ Howard","year":"2014","journal-title":"BJOG"},{"key":"pntd.0010232.ref004","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.anpedi.2017.03.003","article-title":"Seroprevalence and vertical transmission of Chagas disease in a cohort of Latin-American pregnant women in a tertiary hospital in Madrid","volume":"88","author":"L Francisco-Gonz\u00e1lez","year":"2018","journal-title":"An Pediatr (Barc)"},{"key":"pntd.0010232.ref005","doi-asserted-by":"crossref","first-page":"e0218491","DOI":"10.1371\/journal.pone.0218491","article-title":"Congenital transmission of Chagas disease in a non endemic area, is an early diagnosis possible?","volume":"14","author":"L Francisco Gonz\u00e1lez","year":"2019","journal-title":"PLoS ONE."},{"key":"pntd.0010232.ref006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.anpedi.2018.01.005","article-title":"Luces y sombras en la transmisi\u00f3n vertical de la enfermedad de Chagas","volume":"88","author":"MI Gonz\u00e1lez-Tom\u00e9","year":"2018","journal-title":"An Pediatr (Barc)."},{"key":"pntd.0010232.ref007","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eimc.2012.09.010","article-title":"Recomendaciones para el diagn\u00f3stico, seguimiento y tratamiento de la embarazada y del ni\u00f1o con enfermedad de Chagas","volume":"31","author":"MI Gonz\u00e1lez-Tom\u00e9","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"pntd.0010232.ref008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/136485910X12851868780423","article-title":"Gastro-intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis","volume":"105","author":"A P\u00e9rez Ayala","year":"2011","journal-title":"Annals of Tropical Medicine & Parasitology"},{"key":"pntd.0010232.ref009","article-title":"Trypanocidal treatment of Chagas disease","author":"JA P\u00e9rez-Molina","year":"2020","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"5","key":"pntd.0010232.ref010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eimc.2013.04.024","article-title":"Chagas pedi\u00e1trico en zona no end\u00e9mica.","volume":"32","author":"V Fumad\u00f3","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"pntd.0010232.ref011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/INF.0000000000000139","article-title":"Pediatric Chagas Disease in Europe: 45 Cases From Spain and Switzerland","volume":"33","author":"L Rodriguez-Guerineau","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"pntd.0010232.ref012","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cch.12485","article-title":"ISSOP position statement on migrant child health","volume":"44","author":"ISSOP Migration Working Group","year":"2018","journal-title":"Child:Care, Health and Development"},{"key":"pntd.0010232.ref013","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"JA P\u00e9rez Molina","year":"2018","journal-title":"Lancet"},{"key":"pntd.0010232.ref014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.eimc.2012.09.007","article-title":"Comparaci\u00f3n entre t\u00e9cnicas inmunol\u00f3gicas y moleculares para el diagn\u00f3stico de la enfermedad de Chagas","volume":"31","author":"E Ferrer","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"pntd.0010232.ref015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/01443615.2016.1148680","article-title":"Hydrops fetalis in a congenital Chagas case in a non endemic area","volume":"36","author":"T Gasta\u00f1aga-Holguera","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"pntd.0010232.ref016","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jix087","article-title":"Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR","volume":"21","author":"L Murcia","year":"2017","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0010232.ref017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/0074-02760140347","article-title":"Prevention of congenital Chagas through treatment of girls and women of childbearing age","volume":"110","author":"G Moscatelli","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0010232.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES.2020.25.8.1900393","article-title":"Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"25","author":"M Velasco","year":"2020","journal-title":"Euro Surveill"},{"key":"pntd.0010232.ref019","first-page":"494","article-title":"The Clinical and Parasitologic Follow-up of Trypanosoma cruzi\u2013infected Children in a Non endemic Country","volume":"39","author":"M Sim\u00f3n","year":"2020","journal-title":"PIDJ"},{"issue":"8","key":"pntd.0010232.ref020","doi-asserted-by":"crossref","first-page":"e0007668","DOI":"10.1371\/journal.pntd.0007668","article-title":"Longitudinal follow up of serological response in children treated for Chagas disease","volume":"13","author":"G Moscatelli","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0010232.ref021","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Medecins Sans Fronti`eres","volume":"3","author":"O Yun","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010232.ref022","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease","volume":"57","author":"MJ Pinazo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0010232.ref023","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40264-018-0696-5","article-title":"Safety profile of benznidazole in the treatment of chronic Chagas disease: experience of a referral centre and systematic literatura review with meta-analysis","volume":"41","author":"C Crespillo-And\u00fajar","year":"2018","journal-title":"Drug Saf"},{"key":"pntd.0010232.ref024","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/peds.2010-1172","article-title":"Moroni, S Garcia-Bournissen F, Freilij H. Adverse events after the use of benznidazole in infants and children with Chagas disease","volume":"127","author":"J Altchech","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"pntd.0010232.ref025","doi-asserted-by":"crossref","first-page":"e0213577","DOI":"10.1371\/journal.pone.0213577","article-title":"Chagas screening and treatment among Bolivians living in Madrid, Spain: The need for an official protocol","volume":"14","author":"M Romay-Barja","year":"2019","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010232","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T18:50:37Z","timestamp":1646765437000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010232"}},"subtitle":[],"editor":[{"given":"Walderez O.","family":"Dutra","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010232","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0010232","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]}}}